AAA

AKUMS DRUGS AND PHARMA L

No trades
See on Supercharts

AKUMS fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Akums Drugs & Pharmaceuticals Ltd. engages in the manufacturing and marketing of pharmaceutical products and services. It operates segments include Contract Development and Manufacturing Operations (CDMO), Active Pharmaceutical Ingredient (API), and Branded and Generic Formulations. The CDMO segment involves in the formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on contract basis, job work and testing services. The API segment is engaged in manufacturing and sale of KSM, Intermediate and API products. The Branded and Generic Formulations segment is engaged in marketing and distribution of branded and generic pharmaceutical formulations. The firm’s products include tablets, hard gelatin capsules, soft gelatin capsules, powder in sachets, liquid syrups and suspensions, injections, eye/ear drops, ayurveda and herbal preparations, nutraceutical, and cosmetic preparations. The company was founded by Sanjeev Jain and Sandeep Jain on April 19, 2004 and is headquartered in New Delhi, India.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

AKUMS does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company